药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bismuth subsalicylate
Berotralstat
The serum concentration of Berotralstat can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Filgotinib
The serum concentration of Regorafenib can be increased when it is combined with Filgotinib.
Bismuth subsalicylate
Pralsetinib
The serum concentration of Pralsetinib can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Satralizumab
The serum concentration of Regorafenib can be decreased when it is combined with Satralizumab.
Bismuth subsalicylate
Abametapir
The serum concentration of Regorafenib can be increased when it is combined with Abametapir.
Bismuth subsalicylate
Capmatinib
The serum concentration of Regorafenib can be increased when it is combined with Capmatinib.
Bismuth subsalicylate
Sacituzumab govitecan
The serum concentration of Sacituzumab govitecan can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Ozanimod
Regorafenib may decrease the excretion rate of Ozanimod which could result in a higher serum level.
Bismuth subsalicylate
Rimegepant
The serum concentration of Rimegepant can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Ubrogepant
The serum concentration of Ubrogepant can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Lumateperone
The serum concentration of Lumateperone can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Levamlodipine
The serum concentration of Levamlodipine can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Cenobamate
The serum concentration of Cenobamate can be decreased when it is combined with Regorafenib.
Bismuth subsalicylate
Voxelotor
The serum concentration of Voxelotor can be increased when it is combined with Regorafenib.
Bismuth subsalicylate
Lasmiditan
Regorafenib may increase the bradycardic activities of Lasmiditan.
Bismuth subsalicylate
Lefamulin
Regorafenib may decrease the excretion rate of Lefamulin which could result in a higher serum level.
Bismuth subsalicylate
Entrectinib
The metabolism of Entrectinib can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Pexidartinib
Regorafenib may increase the hepatotoxic activities of Pexidartinib.
Bismuth subsalicylate
Alpelisib
The serum concentration of Alpelisib can be increased when it is combined with Regorafenib.